P21 for GLP-1 Cognitive Fog in Pediatric Obesity
P21, a cerebrolysin-derived peptide, is being explored for GLP-1-induced cognitive fog in pediatric obesity. This article reviews its mechanism, an...
Read More →INSIGHTS • UPDATES • EDUCATION
Kitchener Peptides
BLOG & LEARNING HUB
WELCOME TO THE KITCHENER PEPTIDES
BLOG & LEARNING HUB
More than just peptides. Kitchener Peptides is a platform for knowledge and progress. Stay informed with expert insights, research updates, protocols, and everything you need to stay ahead in peptide science.
Latest Articles
Semax as a Nootropic Countermeasure for GLP-1-Induced Cognitive Fog
Semax and P21 are peptide nootropics often floated as fixes for GLP-1 cognitive fog. This article separates the real evidence from the hype, with a...
Read More →Semax and P21 as Neuroprotective Adjuncts for GLP-1 Users
GLP-1 receptor agonists have changed the landscape of metabolic medicine, but a subset of users reports cognitive side effects that blunt the benef...
Read More →Semax and P21 for Cognitive Support During GLP-1-Induced Alcohol Craving Reduction
GLP-1 receptor agonists like semaglutide and tirzepatide have shifted from metabolic treatments to unexpected allies in alcohol use disorder. Clinical
Read More →Semax for GLP-1 Users Facing Cognitive Fatigue from Alcohol Craving Reduction
GLP-1 receptor agonists have changed the landscape for alcohol use disorder, but the cognitive cost of reduced cravings is rarely discussed. As
Read More →P21 Neuroprotection Against Alcohol-Induced Cognitive Decline in the VA's GLP-1 Trial Population
Veterans with alcohol use disorder often face a double threat: metabolic dysfunction and lasting cognitive impairment. The VA's exploration of GLP-1
Read More →